Firms focused on drug discovery, genetic research, and life sciences.
Theme Performance
Equal-weight basket of constituents
1 Day
-1.42%
1 Week
-1.88%
1 Month
-7.09%
3 Months
+4.78%
Year to Date
+2.28%
Constituents
15 active symbols
| Ticker | Company | Market Cap | Price | 1D % | 1W % | 1M % | 3M % | YTD % |
|---|---|---|---|---|---|---|---|---|
| Amgen Inc | $187.488B | $347.8000 | -0.61% | -5.03% | -7.38% | +6.68% | +6.15% | |
| Gilead Sciences Inc | $170.335B | $137.2100 | -2.76% | -5.37% | -9.20% | +13.06% | +12.84% | |
| Vertex Pharmaceuticals Inc | $115.332B | $454.0000 | -0.88% | -3.27% | -3.25% | +1.00% | +0.41% | |
| Regeneron Pharmaceuticals Inc | $78.943B | $732.8700 | -0.62% | -1.73% | -6.33% | -2.26% | -5.60% | |
| Alnylam Pharmaceuticals, Inc. | $41.401B | $312.1700 | +0.34% | -0.40% | -8.01% | -20.39% | -21.99% | |
|
A
ARGX
|
argenx SE American Depositary Shares | $41.086B | $663.9300 | -3.01% | -5.21% | -21.64% | -22.98% | -20.96% |
| Biogen Inc. Common Stock | $26.631B | $181.4600 | -1.06% | -0.05% | -5.53% | +5.44% | +2.05% | |
|
B
BNTX
|
BioNTech SE American Depositary Share | $22.436B | $89.2700 | -0.04% | -2.11% | -19.15% | -2.54% | -7.67% |
| Illumina Inc | $19.010B | $124.3300 | -1.79% | +4.53% | +3.61% | -4.04% | -7.46% | |
| Incyte Genomics Inc | $18.067B | $90.7800 | -2.33% | -1.90% | -10.76% | -7.02% | -10.49% | |
| Moderna, Inc. Common Stock | $17.700B | $51.3800 | -1.89% | -2.25% | +3.38% | +68.40% | +66.49% | |
| Jazz Pharmaceuticals, Inc. | $9.995B | $180.6200 | -0.65% | +1.16% | +6.50% | +9.52% | +4.31% | |
| CRISPR Therapeutics AG | $4.438B | $46.2400 | -1.51% | -5.15% | -15.37% | -15.53% | -14.00% | |
| Beam Therapeutics Inc. Common Stock | $2.509B | $24.6300 | -2.15% | -2.11% | -11.66% | -3.79% | -9.25% | |
| Intellia Therapeutics, Inc | $1.517B | $12.8400 | -2.36% | +0.63% | -1.53% | +46.08% | +39.41% |
